Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan.
Takenaka, Katsuto
Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan. [electronic resource] - International journal of hematology Jan 2017 - 59-69 p. digital
Publication Type: Journal Article
1865-3774
10.1007/s12185-016-2102-3 doi
Adult
Androgens--therapeutic use
Antineoplastic Agents--therapeutic use
Cohort Studies
Erythrocyte Transfusion
Female
Hematopoietic Stem Cell Transplantation
Humans
Hydroxyurea--therapeutic use
Japan--epidemiology
Karyotype
Male
Middle Aged
Nitriles
Platelet Transfusion
Primary Myelofibrosis--diagnosis
Prognosis
Pyrazoles--therapeutic use
Pyrimidines
Splenectomy
Surveys and Questionnaires
Survival Rate
Treatment Outcome
Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan. [electronic resource] - International journal of hematology Jan 2017 - 59-69 p. digital
Publication Type: Journal Article
1865-3774
10.1007/s12185-016-2102-3 doi
Adult
Androgens--therapeutic use
Antineoplastic Agents--therapeutic use
Cohort Studies
Erythrocyte Transfusion
Female
Hematopoietic Stem Cell Transplantation
Humans
Hydroxyurea--therapeutic use
Japan--epidemiology
Karyotype
Male
Middle Aged
Nitriles
Platelet Transfusion
Primary Myelofibrosis--diagnosis
Prognosis
Pyrazoles--therapeutic use
Pyrimidines
Splenectomy
Surveys and Questionnaires
Survival Rate
Treatment Outcome